Honey flower dermatitis: Contact allergy to ellagic acid in Melianthuscomosus.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 27 04 2023
revised: 11 07 2023
accepted: 20 07 2023
medline: 7 9 2023
pubmed: 24 7 2023
entrez: 23 7 2023
Statut: ppublish

Résumé

A case study is reported whereby a patient with no prior allergies developed a strong and spreading delayed-type hypersensitivity reaction to Melianthus plants, nectar and synthetic pigment derived from it after frequent handling of these substances. The lesions improved after treatment with topical steroids and allergen avoidance within 1-2 weeks. Subsequent patch testing with the plants, nectar and synthetic ingredients identified ellagic acid (EA) as the sensitizing agent. This is the first proven case of allergic contact dermatitis to EA, a phenolic substance present in numerous plants, fruits, and nuts regularly consumed by humans. Melianthus use is growing worldwide as an ornamental plant. Moreover, it is used in traditional South African medicine for its anti-inflammatory effects. In recent years, these extracts and EA have been added to natural, plant-based topical formulations for the treatment of inflammatory skin disorders. Our observation that the EA found in Melianthus can induce severe contact allergy should caution for the possible dangers of specific allergic sensitizations to these increasingly used additives in natural medicines.

Identifiants

pubmed: 37482193
pii: S0278-6915(23)00358-7
doi: 10.1016/j.fct.2023.113956
pii:
doi:

Substances chimiques

Ellagic Acid 19YRN3ZS9P
Plant Nectar 0
Allergens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113956

Informations de copyright

Copyright © 2023. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Puneet Arora (P)

Department of Dermatology, University of Minnesota, Minneapolis, MN, 55455, USA.

Evin T Magner (ET)

Department of Plant & Microbial Biology, University of Minnesota, St. Paul, MN, 55108, USA.

Paul L Bigliardi (PL)

Department of Dermatology, University of Minnesota, Minneapolis, MN, 55455, USA. Electronic address: pbigliar@umn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH